The application of epigenetic modifiers on the treatment of prostate and bladder cancer

Urologic Oncology
Zhengwang ZhangJer-Tsong Hsieh

Abstract

Prostate cancer and transitional cell carcinoma (TCC) of bladder are the 2 most common malignancies in the male adult urogenital system. Epigenetic gene silencing, particularly tumor suppressor genes, has become a new area of cancer research. Agents such as deoxyribonucleic acid methyltransferase inhibitors or histone deacetylase inhibitors are epigenetic modifiers that can restore gene expression and alter the malignant phenotype of cancer. They provide a new therapeutic avenue for prostate cancer and TCC. It is also likely that combination regimens using epigenetic modifiers with other classes of agents may have higher therapeutic efficacy for prostate cancer and TCC, especially metastatic and/or refractory cases. We review current knowledge of epigenetic event in prostate cancer and TCC, and discuss the possible clinical implications for these 2 diseases.

References

Nov 1, 1981·Journal of Pharmaceutical Sciences·K T LinG E Rivard
Apr 1, 1980·European Journal of Biochemistry·H Sano, R Sager
Dec 6, 1994·Proceedings of the National Academy of Sciences of the United States of America·R JüttermannR Jaenisch
Dec 19, 1996·Nature·A J Bannister, T Kouzarides
Apr 29, 1997·Proceedings of the National Academy of Sciences of the United States of America·L Jackson-GrusbyR Jaenisch
Jan 1, 1996·Investigational New Drugs·P M LoRussoT H Corbett
Apr 18, 1998·Proceedings of the National Academy of Sciences of the United States of America·V M RichonP A Marks
Feb 6, 1999·International Journal of Cancer. Journal International Du Cancer·N S VerkaikG J Van Steenbrugge
Oct 16, 1999·Science·A P Wolffe, M A Matzke
Aug 24, 2000·Proceedings of the National Academy of Sciences of the United States of America·V M RichonP A Marks
Sep 27, 2000·Human Molecular Genetics·T H Bestor
Feb 15, 2001·The Prostate·J CuiA R Brothman
Sep 21, 2001·Biochemical and Biophysical Research Communications·S K PatraR Dahiya
Dec 19, 2001·Journal of Korean Medical Science·W B ChungJ W Kim
Jan 5, 2002·Molecular and Cellular Biology·Gangning LiangPeter A Jones
Jan 25, 2002·International Journal of Cancer. Journal International Du Cancer·Mitsuhiro SuenagaShigeru Kohno
Mar 1, 2002·Molecular Carcinogenesis·Samir K PatraRajvir Dahiya
Apr 5, 2002·Nature·Ina RheeBert Vogelstein
May 7, 2002·The Prostate·Satoru TakahashiTomoyuki Shirai
Jun 25, 2002·Japanese Journal of Cancer Research : Gann·Hiroshi FukuharaYoshinori Murakami
Aug 1, 2002·Japanese Journal of Cancer Research : Gann·Noboru KonishiKeiji Shimada
Aug 31, 2002·Molecular Carcinogenesis·Leopoldo Alves Ribeiro-FilhoRajvir Dahiya
Oct 3, 2002·Oncogene·Limin LiuGerd P Pfeifer
Oct 11, 2002·Nature·Sooryanarayana VaramballyArul M Chinnaiyan
Nov 7, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J Goffin, E Eisenhauer
Nov 26, 2002·The Journal of Biological Chemistry·Hong ChenJer-Tsong Hsieh
Dec 25, 2002·Journal of Clinical Pathology·C JerónimoD Sidransky
Feb 21, 2003·International Journal of Cancer. Journal International Du Cancer·Fumihiro KimuraWolfgang A Schulz
Mar 6, 2003·Journal of the National Cancer Institute·Jonathan C ChengEric U Selker
Mar 21, 2003·Cancer Genetics and Cytogenetics·Bao-Zhu YuanNicholas C Popescu
May 29, 2003·Current Medicinal Chemistry. Anti-cancer Agents·Wei-Guo Zhu, Gregory A Otterson
Jun 10, 2003·The Journal of Biological Chemistry·Andrea HermannAlbert Jeltsch
Jul 8, 2003·International Journal of Cancer. Journal International Du Cancer·Mikio YamanakaTaizo Shiraishi
Jul 11, 2003·The Journal of Urology·Lin-Li ChangChun-Hsiung Huang

❮ Previous
Next ❯

Citations

Jul 19, 2008·The Journal of Urology·Deborah W Knapp
Jan 14, 2011·The Journal of Molecular Diagnostics : JMD·Maria José CabelloMarta Sánchez-Carbayo
Jan 4, 2007·The Journal of Pathology·N SampsonP Berger
Sep 18, 2007·Medical Oncology·Victor ValdespinoPavel Pisa
Jun 29, 2011·Expert Review of Anticancer Therapy·Nozomu TanjiMasayoshi Yokoyama
Mar 17, 2019·International Journal of Molecular Sciences·Aikaterini F GiannopoulouDimitrios J Stravopodis
Oct 9, 2008·Journal of Medicinal Chemistry·Salvatore Di MaroJung-Mo Ahn

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics and Chromatin (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin and its role in cancer epigenetics please follow this feed to learn more.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics Chromatin Complexes (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin complexes and their role in cancer epigenetics.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Related Papers

Seminars in Hematology
Guillermo Garcia-Manero, Steven D Gore
Genes & Development
Anders H Lund, Maarten van Lohuizen
© 2021 Meta ULC. All rights reserved